4Front Ventures Corp. (FFNTF) Financial Statements (2025 and earlier)
Company Profile
Business Address |
7010 E. CHAUNCEY LANE STE. 235 PHOENIX, AZ 85054 |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 12/31/2023 | 12/31/2021 | 12/31/2020 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 3,398 | 22,610 | 18,932 | |||
Cash and cash equivalent | 3,398 | 22,610 | 18,932 | |||
Receivables | 4,417 | 2,344 | 5,492 | |||
Inventory, net of allowances, customer advances and progress billings | 17,087 | 20,087 | 18,037 | |||
Inventory | 17,087 | 20,087 | 18,037 | |||
Prepaid expense | 2,232 | 2,275 | ||||
Disposal group, including discontinued operation | 1,696 | |||||
Other undisclosed current assets | 7,314 | 3,601 | ||||
Total current assets: | 33,912 | 50,874 | 44,736 | |||
Noncurrent Assets | ||||||
Operating lease, right-of-use asset | 118,511 | 62,466 | ||||
Nontrade receivables | 7,595 | |||||
Property, plant and equipment | 36,549 | 42,633 | 33,618 | |||
Long-term investments and receivables | 91 | |||||
Accounts and financing receivable, after allowance for credit loss | 91 | |||||
Intangible assets, net (including goodwill) | 68,600 | 49,401 | 51,945 | |||
Goodwill | 41,807 | 23,155 | 23,155 | |||
Intangible assets, net (excluding goodwill) | 26,793 | 26,246 | 28,790 | |||
Deposits noncurrent assets | 2,419 | 5,364 | 4,305 | |||
Other undisclosed noncurrent assets | 3,963 | 107,267 | ||||
Total noncurrent assets: | 230,042 | 204,665 | 160,020 | |||
TOTAL ASSETS: | 263,954 | 255,539 | 204,756 | |||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities | 51,049 | 26,099 | 16,224 | |||
Taxes payable | ✕ | ✕ | 23,968 | 11,502 | ||
Accounts payable | 11,415 | 2,131 | 4,722 | |||
Accrued liabilities | 39,634 | |||||
Debt | 25,630 | 6,197 | 5,024 | |||
Derivative instruments and hedges, liabilities | 4,550 | 3,502 | 5,807 | |||
Disposal group, including discontinued operation | 12,037 | |||||
Business combination, contingent consideration, liability | 2,393 | |||||
Other undisclosed current liabilities | 10,734 | 13,040 | 8,336 | |||
Total current liabilities: | 104,000 | 48,838 | 37,784 | |||
Noncurrent Liabilities | ||||||
Long-term debt and lease obligation | 58,543 | 157,727 | 113,536 | |||
Long-term debt, excluding current maturities | 58,543 | 64,616 | 61,991 | |||
Liabilities, other than long-term debt | 135,828 | 10,242 | 9,633 | |||
Deferred income tax liabilities | 11,882 | 7,849 | 6,530 | |||
Operating lease, liability | 123,946 | 93,111 | 51,545 | |||
Business combination, contingent consideration, liability | 2,393 | 3,103 | ||||
Other undisclosed noncurrent liabilities | 16,977 | 1,200 | 1,600 | |||
Total noncurrent liabilities: | 211,348 | 169,169 | 124,769 | |||
Total liabilities: | 315,348 | 218,007 | 162,553 | |||
Equity | ||||||
Equity, attributable to parent, including: | (51,502) | 37,460 | 42,151 | |||
Additional paid in capital | 66,948 | 52,197 | 42,116 | |||
Accumulated deficit | (427,402) | (288,857) | (250,548) | |||
Other undisclosed equity, attributable to parent | 308,952 | 274,120 | 250,583 | |||
Equity, attributable to noncontrolling interest | 108 | 72 | 52 | |||
Total equity: | (51,394) | 37,532 | 42,203 | |||
TOTAL LIABILITIES AND EQUITY: | 263,954 | 255,539 | 204,756 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2021 | 12/31/2020 | ||
---|---|---|---|---|---|
Revenues | 97,435 | 104,566 | 57,635 | ||
Cost of revenue (Cost of Product and Service Sold) | (51,543) | ||||
Other undisclosed gross profit | (55,170) | (21,124) | |||
Gross profit: | 45,892 | 49,396 | 36,511 | ||
Operating expenses | (66,739) | (63,502) | (69,121) | ||
Operating loss: | (20,847) | (14,106) | (32,610) | ||
Nonoperating income (expense) | (16,779) | 62 | 81 | ||
Investment income, nonoperating | (385) | 15 | (682) | ||
Other nonoperating income (expense) | (2,469) | 47 | 763 | ||
Interest and debt expense | 29 | (13,704) | (14,181) | ||
Loss from continuing operations before equity method investments, income taxes: | (37,597) | (27,748) | (46,710) | ||
Other undisclosed income (loss) from continuing operations before income taxes | (29) | 3,390 | 1,767 | ||
Loss from continuing operations before income taxes: | (37,626) | (24,358) | (44,943) | ||
Income tax expense | (7,092) | (13,931) | (15,049) | ||
Loss from continuing operations: | (44,718) | (38,289) | (59,992) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (38,289) | (47,005) | |
Income (loss) from discontinued operations | (46,914) | 12,987 | |||
Net loss: | (91,632) | (38,289) | (47,005) | ||
Net loss attributable to noncontrolling interest | (15) | (20) | (46) | ||
Other undisclosed net income attributable to parent | 76,618 | ||||
Net income (loss) available to common stockholders, diluted: | (91,647) | 38,309 | (47,051) |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2021 | 12/31/2020 | ||
---|---|---|---|---|---|
Net loss: | (91,632) | (38,289) | (47,005) | ||
Comprehensive loss: | (91,632) | (38,289) | (47,005) | ||
Comprehensive loss, net of tax, attributable to noncontrolling interest | (15) | (20) | (46) | ||
Comprehensive loss, net of tax, attributable to parent: | (91,647) | (38,309) | (47,051) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.